Last update 01 Nov 2024
Zhejiang Qo Tuo Kang Pharmaceutic

Zhejiang Qo Tuo Kang Pharmaceutic

Private Company|
1994|
Zhejiang Sheng, China
|
www.ziatk.com

Overview

Tags

Other Diseases
Urogenital Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
GABAA receptor(Gamma-aminobutyric acid A receptor)1

Related

1
Drugs associated with Zhejiang Qo Tuo Kang Pharmaceutic
Flumazenil
Target
GABAA receptor
Mechanism
GABAA receptor antagonists
Active Org.
Zhejiang Qo Tuo Kang PharmaceuticZhejiang Qo Tuo Kang Pharmaceutic [+2]
Originator Org.
F. Hoffmann-La Roche Ltd. [+1]
Active Indication
Hyperemesis Gravidarum [+2]
Inactive Indication
Consciousness [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date20 Dec 1991
1
Clinical Trials associated with Zhejiang Qo Tuo Kang Pharmaceutic
CTR20190650 / Completed
随机、开放、两制剂、两周期对照设计，评价健康受试者空腹状态下单次口服50mg硫唑嘌呤片的生物等效性试验
[Translation] A randomized, open-label, two-dose, two-period controlled study to evaluate the bioequivalence of a single oral dose of 50 mg azathioprine tablets in healthy subjects under fasting conditions
100 Clinical Results associated with Zhejiang Qo Tuo Kang Pharmaceutic
Login to view more data
0 Patents (Medical) associated with Zhejiang Qo Tuo Kang Pharmaceutic
Login to view more data
100 Deals associated with Zhejiang Qo Tuo Kang Pharmaceutic
Login to view more data
100 Translational Medicine associated with Zhejiang Qo Tuo Kang Pharmaceutic
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 13 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Flumazenil
 ( GABAA receptor )		Hyperemesis Gravidarum
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free